drugset / Trial / NCT07334002

The Effects of Conventional Therapy on Tinnitus, Disability, and Quality of Life in Patients With Tinnitus

NCT07334002

RandomizedParallel-groupSingle-blindTreatment

Summary

A randomized, single-blind, controlled trial to evaluate the effects of neural therapy on tinnitus severity, disability, and quality of life in patients with tinnitus. The study is planned to be conducted between December 2025 and March 2026. The sample size is 30 patients. The number of centers is 1. The study duration is 3 months.

Timeline

Start
2026-03-01
Primary completion
2026-05-15
Completion
2026-05-26

Drugs

EvaluationDrugModalityDoseRoute
Comparator Betahistine Small molecule 24 mg

Indications